Share

February 26, 2019; 92 (9) Article

Effect of aerobic exercise on cognition in younger adults

A randomized clinical trial

Yaakov Stern, Anna MacKay-Brandt, Seonjoo Lee, Paula McKinley, Kathleen McIntyre, Qolamreza Razlighi, Emil Agarunov, Matthew Bartels, Richard P. Sloan
First published January 30, 2019, DOI: https://doi.org/10.1212/WNL.0000000000007003
Full PDF
Short Form
Citation
Permissions

Make Comment

See Comments

Downloads
674

Share

This article has a correction. Please see:

Article Information

vol. 92 no. 9 e905-e916
DOI: 
https://doi.org/10.1212/WNL.0000000000007003
PubMed: 
30700591
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received July 4, 2018
  • Accepted in final form October 8, 2018
  • First Published January 30, 2019.

Article Versions

Copyright & Usage: 
© 2019 American Academy of Neurology

Author Disclosures

    1. Yaakov Stern, PhD,
    2. Anna MacKay-Brandt, PhD,
    3. Seonjoo Lee, PhD,
    4. Paula McKinley, PhD,
    5. Kathleen McIntyre, LCSW,
    6. Qolamreza Razlighi, PhD,
    7. Emil Agarunov, BS,
    8. Matthew Bartels, MD, MPH and
    9. Richard P. Sloan, PhD
  1. Yaakov Stern, PhD,
    2. Scientific Advisory Boards:

    1. (1) Effects on a bicycling intervention on cognitive skills and cardiovascular health (BIKE). (2) Cognitive intervention to improve simple and complex walking (CREM).

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 2014: (1) Chicago, Alzheimer's Association (MSAC), Advisory Board Meeting, Reimbursement; (2) Barcelona, Spain, International Debate on Ageing and mental health, reimbursement; (3) Chicago, AAAS, Symposium: The Science of Resilient Aging, reimbursement; (4) Washington, D.C., IOM, Workshop on Cognitive Aging, reimbursement; (5) Philadelphia, ADNI, Steering Committee Meeting, reimbursement; (6) Boston, MA, Delirium PPG SAB-Planning of 2014, Reimbursement; (7) Copenhagen, Denmark, AAIC Annual Meeting, AIC and Lilly Symposium, Honorarium; (8) Philadelphia, Eli Lilly, Honorarium; (9) Boston, Delta Quest Foundation, Honorarium; 2015: (10) Dallas, TX, Eli Lilly, Working Group Mtg, Honorarium (11) Dallas, TX, Eli Lilly Outcome Mtg, Honorarium; (12) London, UK, Boston Healthcare Associates, Inc., Alzheimer?s Advisory Bd Mtg, Honorarium; 2016: (13) Utrecht, NL, Dutch Society for Neuropsychology, Annual Conference, Honorarium (14) Seattle, WA, NAN Annual Conference, Keynote, Honorarium. (15) Manchester, UK, Axovant, NICE Meeting, Honorarium; 2017: (16) Miami, FL, Lilly, Preclinical AD Working Group, Honorarium. (17) New York, NY, Axovant, Steering Cte Mtg & GAS Mtg, Honorarium. (18) Carmel, CA, California Walnut Commission, SAC Mtg, Reimbursement. (19) Cleveland, OH, Alzheimer's Association Cleveland Area Chapter, Foley Lecture, Reimbursement. 2018: (20) Geneva, CH, The Center for the Interdisciplinary Study of Gerontology and Vulnerability (CIGEV), Workshop on CR, reimbursement. (21) Dallas, TX, Center for Brainhealth, Distinguished Lecture, reimbursement. (22) Baltimore, MD, Annual Meeting of Johns Hopkins ADRC, reimbursement. (23) Gramado, Brazil, Congress of Brain, Behavior and Emotions, reimbursement. (24) Washington, DC, CP Study section, honorarium and reimbursement. (25) Chicago, IL, AAIC Annual Meeting. (26) Toronto, CA, IFA 14th Global Conference on Ageing. (27) Lake Tahoe, CA, Advanced Psychometric Methods in Cognitive Aging Research conference, reimbursement

    Editorial Boards:

    1. (1) Journal of the International Neuropsychological Society, Editorial Board 2013- present, (2)Cognitive and Behavioral Neurology, Editorial Board, 2005-present, (3)Neuropsychology, Editorial Board, 2006-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Eli Lilly, (2) AbbVie Inc. (3) Takeda Global Research & Development Center Inc. (4) Piramal Imaging SA (5) AXOVANT

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1)Piramal, (2) AXOVANT, (3) California Walnut Commission

    Research Support, Government Entities:

    1. (1) NIH/NIA, R01AG034178, PI, 2009-2013. (2) NIH/NIA, 5R01AG007370, PI, 1989-2022. (3) NIH/NIA, R01AG037212-05, Co-I, 2010-2016. (4) NIH/NIA, P50 AG08702- 25, Co-I, 1998-. (5) NIH/NIA, R01AG038465-04, PI, 2011- (6) NIH/NIA, RF1AG038465, PI, 2011-(7) NIH/NIA, R01AG033546-05, PI 2010-. (8) NIH/NIA, R01AG026158, PI, 2004-2022. (9) NIH/NINDS, R01NS070600-03, Co-I, 2010-2015. (10) NIH/NIA, R37NS029993- 21, Co-I, 2013-2015. (11) NIH/Fogarty, R01AG036469-03, Co-I, 2011-2017 17. (12) NIH, R01AG041795-01A1, Co-I, 2013-2018. (13) NIA, R01AG043463, Co-I, 2012-2018. (14) NIH/NIA, R01AG043679-01A1, Co-I, 2014-19. (15) NIH/NIA, R21AG053202, Co-I, 2016-18. (16) NICHHD, R01HD082176, Co-I, 2016-21. (17) NIH/NIA, R01AG050819, Co-I, 2016-21. (18) NIMD, 1R61MH110029, Co-I, 2016-18 (19) CWC-CU,15-3273, Co-I, 2015- 17. (19) NIA/NIA, P50AG008702-25, 1997-2020. (20) NIH/NIA 1R24AG061421-01, PI, 2018-2021. (21) HRS-18-586069C, Co-I, 2018-2019. (22) NICHHD R01HD082176, Co-I, 2016-2021. (23) NIH, R01AG057962, Co-I, 2018-2023. (24) NIH/NIA P50AG008702-25, Co-I, 1997-2020. (25) NIH/NINDS, R01 NS029993, Co-I, 2015-2020. (26) NIA, 1R56AG057202-01, Co-I, 2017-2018. (27) NIH, R01 HL139489, Co-I, 2017-2021. (28) NIH, R01AG055422, Co-I, 2017-2022. (29)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License fee payments, Technology or Inventions:

    1. (1) The Dependence Scale measures is licensed for use by commercial entities by Columbia University, and I receive funds from these licenses.

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Anna MacKay-Brandt, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Seonjoo Lee, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Paula McKinley, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Salary support from grant that funded the study reported in this paper: NIH/NIA Grant: 5 R01 AG033546-05; My role: co-investigator; (PIs: Stern/Sloan); 2010-2016

    Research Support, Academic Entities:

    1. (1) 2016-2017: was employed and salary supported full-time by Montefiore Medical Center; Support by PCORI contract #HPC-1503-28122 (PI: Litwin). My Role: project director. Work was unrelated to the study reported in this paper.

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Kathleen McIntyre, LCSW,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Qolamreza Razlighi, PhD,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Emil Agarunov, BS,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Matthew Bartels, MD, MPH and
    9. Scientific Advisory Boards:

    1. 1) NIH trial DSMB for a study of exercise and Pulmonary Hypertension. 20 Medical Advisory Board for EHE Medical, NY, NY - advice on exercise physiology and wellness.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. LIH Healthcare , Beijing China. For medical consulting, Payment for travel to China - paid to my department and institution.

    Editorial Boards:

    1. PM&R journal, Associate Editor 2007 to present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Grant Support: Improving Cognition via Exercise in Schizophrenia. R01 MH 110623 (Kimhy, David PI) Co-Investigator, (10% support) 9/1/17-8/30/22

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Everest Foundation Support: Evaluation of improvements in Back Pain and Knee Pain with a Biomechanical Device to Alter Gait Mechanics. 1/2016-12/2018. Total $300,000, $100,000 per year. Everest Foundation Support: 3D Printing for Prosthetics and Orthotics in 3rd world and 1st World Settings. 1/2016-12/2018. Total $300,000, $100,000 per year.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Richard P. Sloan, PhD
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIA, R01 AG058417, PI, 2018-2023 DOD, W81XWH 14-1-0236, PI, 2014-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Cognitive Neuroscience Division, Department of Neurology and Taub Institute (Y.S., A.M.-B., Q.R., E.A.), Department of Biostatistics (S.L.), and Department of Psychiatry, Division of Behavioral Medicine (P.M., K.M., R.P.S.), Columbia University, New York; Division of Clinical Research (A.M.-B.), Nathan Kline Institute for Psychiatric Research, Orangeburg; Division of Biostatistics (S.L.), New York State Psychiatric Institute; and Cardiopulmonary Rehabilitation and the Human Performance Laboratory (M.B.), Columbia Presbyterian Medical Center, New York, NY.
  1. Correspondence
    Dr. Stern ys11{at}columbia.edu
View Full Text

Article usage

Article usage: January 2019 to February 2021

AbstractFullPdfSource
Jan 20191519032Highwire
Feb 20198646118269Highwire
Mar 20194195191100Highwire
Apr 201919416850Highwire
May 20196983827Highwire
Jun 20194721917Highwire
Jul 2019476289Highwire
Aug 20195063112Highwire
Sep 20193861713Highwire
Oct 20194322712Highwire
Nov 20194161613Highwire
Dec 201940654Highwire
Jan 20205392214Highwire
Feb 2020523115Highwire
Mar 20206101010Highwire
Apr 20205602128Highwire
May 202044027Highwire
Jun 2020335916Highwire
Jul 202044272Highwire
Aug 2020342141Highwire
Sep 2020411176Highwire
Oct 202059355Highwire
Nov 20205182112Highwire
Dec 202068792Highwire
Jan 202165082Highwire
Feb 202158586Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Related Articles

Topics Discussed

Alert Me